{"id":14152,"date":"2018-02-15T11:43:47","date_gmt":"2018-02-15T11:43:47","guid":{"rendered":"https:\/\/celonpharma.com\/?page_id=14152"},"modified":"2018-02-16T14:55:44","modified_gmt":"2018-02-16T14:55:44","slug":"communications-and-investor-relations-departament","status":"publish","type":"page","link":"https:\/\/celonpharma.com\/en\/communications-and-investor-relations-departament\/","title":{"rendered":"Investor Relations Celon Pharma S.A."},"content":{"rendered":"<h6>Ma\u0142gorzata Siewierska &#8211; Communications and Investor Relations Officer<br \/>\ntel: 519 066 531<br \/>\ne-mail: <a class=\"mail\" href=\"mailto: inwestorzy@celonpharma.com\"> inwestorzy@celonpharma.com<br \/>\n<\/a>Management Office<br \/>\nOgrodowa 2A<br \/>\n05-092 \u0141omianki\/Kie\u0142pin<\/h6>\n","protected":false},"excerpt":{"rendered":"<p>Ma\u0142gorzata Siewierska &#8211; Communications and Investor Relations Officer tel: 519 066 531 e-mail: inwestorzy@celonpharma.com Management Office Ogrodowa 2A 05-092 \u0141omianki\/Kie\u0142pin<\/p>\n","protected":false},"author":11,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-14152","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Investor Relations Celon Pharma S.A. - Celon Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celonpharma.com\/en\/communications-and-investor-relations-departament\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Investor Relations Celon Pharma S.A. - Celon Pharma\" \/>\n<meta property=\"og:description\" content=\"Ma\u0142gorzata Siewierska &#8211; Communications and Investor Relations Officer tel: 519 066 531 e-mail: inwestorzy@celonpharma.com Management Office Ogrodowa 2A 05-092 \u0141omianki\/Kie\u0142pin\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celonpharma.com\/en\/communications-and-investor-relations-departament\/\" \/>\n<meta property=\"og:site_name\" content=\"Celon Pharma\" \/>\n<meta property=\"article:modified_time\" content=\"2018-02-16T14:55:44+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/communications-and-investor-relations-departament\\\/\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/communications-and-investor-relations-departament\\\/\",\"name\":\"Investor Relations Celon Pharma S.A. - Celon Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\"},\"datePublished\":\"2018-02-15T11:43:47+00:00\",\"dateModified\":\"2018-02-16T14:55:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/communications-and-investor-relations-departament\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/celonpharma.com\\\/en\\\/communications-and-investor-relations-departament\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/communications-and-investor-relations-departament\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investor Relations Celon Pharma S.A.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\",\"name\":\"Celon Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Investor Relations Celon Pharma S.A. - Celon Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celonpharma.com\/en\/communications-and-investor-relations-departament\/","og_locale":"en_US","og_type":"article","og_title":"Investor Relations Celon Pharma S.A. - Celon Pharma","og_description":"Ma\u0142gorzata Siewierska &#8211; Communications and Investor Relations Officer tel: 519 066 531 e-mail: inwestorzy@celonpharma.com Management Office Ogrodowa 2A 05-092 \u0141omianki\/Kie\u0142pin","og_url":"https:\/\/celonpharma.com\/en\/communications-and-investor-relations-departament\/","og_site_name":"Celon Pharma","article_modified_time":"2018-02-16T14:55:44+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/celonpharma.com\/en\/communications-and-investor-relations-departament\/","url":"https:\/\/celonpharma.com\/en\/communications-and-investor-relations-departament\/","name":"Investor Relations Celon Pharma S.A. - Celon Pharma","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/#website"},"datePublished":"2018-02-15T11:43:47+00:00","dateModified":"2018-02-16T14:55:44+00:00","breadcrumb":{"@id":"https:\/\/celonpharma.com\/en\/communications-and-investor-relations-departament\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celonpharma.com\/en\/communications-and-investor-relations-departament\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/celonpharma.com\/en\/communications-and-investor-relations-departament\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celonpharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"Investor Relations Celon Pharma S.A."}]},{"@type":"WebSite","@id":"https:\/\/celonpharma.com\/en\/#website","url":"https:\/\/celonpharma.com\/en\/","name":"Celon Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celonpharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/pages\/14152","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/comments?post=14152"}],"version-history":[{"count":3,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/pages\/14152\/revisions"}],"predecessor-version":[{"id":14318,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/pages\/14152\/revisions\/14318"}],"wp:attachment":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/media?parent=14152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}